Article
Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
PloS one - 1 Jan 2016
Park Jangchul, Kobayashi Yoshihisa, Urayama Kevin Y, Yamaura Hidekazu, Yatabe Yasushi, Hida Toyoaki
Abstract excerpt
This study aimed to identify the computed tomography characteristics of treatment-naïve patients with lung adenocarcinoma and known driver mutations in EGFR, KRAS, or ALK. Patients with advanced lung adenocarcinoma (stage IIIB-IV) and known mutations in EGFR, KRAS, or ALK were assessed. The radiological findings for the main tumor and intra-thoracic status were retrospectively analyzed in each group, and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
